How a trusted advisor can help pharma players maximize return on their digital investments
Many players in the pharma industry are making investments in digital solutions in order to enhance their calibration processes. But how can you make sure these investments pay off and do not negatively affect...
Adapting to trends in the pharmaceutical industry
Recent trends in the research-based pharmaceuticals industry, including personalized medicine, flexible production facilities, and digitalization are impacting established processes and requiring new ways of thinking.
For example, personalized medicine –treatment targeted to the individual based...
Viral Vector Vaccine Manufacture: A Glance at the Future on our Doorstep
Today, within the pandemic situation, mRNA or gene therapy is no longer unknown to us. Whether you are a gardener, computer engineer, or dentist, we have all received an accelerated course on how biologics...
Accelerating Asia’s digital GMP transformation with industry 4.0 technologies
In the IDC Info Brief: "Good Manufacturing Practices for Asia/Pacific Pharmaceutical Companies: Accelerating Transformation with Manufacturing 4.0” published in June 2021 and sponsored by Cognizant and Zenith, IDC analysts found organizations in Asia are...
How the Pharmaceutical Industry can keep up with regulatory requirements
Being aware that maintenance has a big influence on both compliance of pharmaceutical processes and the quality of products, observant business owners are beginning to realize the undeniable advantages of controlling and planning maintenance...
Samsung Biologics – how are CDMOs affected post Covid commentary
Impact of COVID-19 on Biopharma CDMO Market: Innovation and Investment
The COVID-19 pandemic has strained resources across the globe and impacted nearly every sector. Arguably, it has been most acutely felt in the pharmaceutical space.
While...
AES Clean Technology Post-COVID Supply Chain Commentary
OCT 2021 At AES Clean Technology, we had front-row seats to many of the challenges and triumphs created by the pandemic. There were several factors affecting the supply chain that changed the way we...
INCOG: Supply chain commentary
Tedd Green, COO at INCOG Biopharma Services discusses the supply chain challenges that pharmaceutical companies have faced due to the COVID-19 pandemic and what the future of the pharma supply chain looks like.
From...
ChargePoint Technology: Post-COVID Supply Chain Commentary
The pharmaceutical industry and its supply chain have both undergone considerable upheaval due to the COVID-19 pandemic. The closure of factories in Asia producing the bulk of the world’s supply of active pharmaceutical ingredients...
A Strong Partnership in Drug Development – How CDMOs and Consultants Mutually Benefit Their...
The field of drug development can be risky and a costly investment - mistakes can mean the success or failure of a compound or even a company. And, while demands for specialized treatments and...